{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:43:07Z","timestamp":1791614587122,"version":"4.3.4"},"reference-count":33,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2021,1,30]]},"DOI":"10.1536\/ihj.20-519","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T22:06:44Z","timestamp":1608934004000},"page":"142-147","source":"Crossref","is-referenced-by-count":7,"title":["The Clinical Efficacy of N-Acetylcysteine in the Treatment of ST Segment Elevation Myocardial Infarction"],"prefix":"10.1536","volume":"62","author":[{"given":"Shi-Jun","family":"Jiang","sequence":"first","affiliation":[{"name":"School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hu","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Affiliated Taihe Hospital of Hubei University of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 2014; 35: 2950-9.","DOI":"10.1093\/eurheartj\/ehu299"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Weintraub WS, Daniels SR, Burke LE, <i>et al<\/i>; American Heart Association Advocacy Coordinating Committee; Council on Cardiovascular Disease in the Young; Council on the Kidney in Cardiovascular Disease; Council on Epidemiology and Prevention; Council on Cardiovascular Nursing; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Clinical Cardiology, and Stroke Council. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation 2011; 124: 967-90.","DOI":"10.1161\/CIR.0b013e3182285a81"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. DeWood MA, Spores J, Notske R, <i>et al<\/i>. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897-902.","DOI":"10.1056\/NEJM198010163031601"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Moran AE, Forouzanfar MH, Roth GA, <i>et al<\/i>. The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation 2014; 129: 1493-501.","DOI":"10.1161\/CIRCULATIONAHA.113.004046"},{"key":"5","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.3390\/molecules23123305","volume":"23","year":"2018","unstructured":"5. Tardiolo G, Bramanti P, Mazzon E. Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases. Molecules 2018; 23: 3305.","journal-title":"Molecules","ISSN":"https:\/\/id.crossref.org\/issn\/1420-3049","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Abe M, Takiguchi Y, Ichimaru S, Tsuchiya K, Wada K. Comparison of the protective effect of N-acetylcysteine by different treatments on rat myocardial ischemia-reperfusion injury. J Pharmacol Sci 2008; 106: 571-7.","DOI":"10.1254\/jphs.FP0071664"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Horowitz JD, Henry CA, Syrjanen ML, <i>et al<\/i>. Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris. Circulation 1988; 77: 787-94.","DOI":"10.1161\/01.CIR.77.4.787"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Eshraghi A, Talasaz AH, Salamzadeh J, <i>et al<\/i>. Evaluating the Effect of Intracoronary N-Acetylcysteine on Platelet Activation Markers After Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction. Am J Ther 2016; 23: e44-51.","DOI":"10.1097\/MJT.0000000000000309"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Marenzi G, Assanelli E, Marana I, <i>et al<\/i>. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006; 354: 2773-82.","DOI":"10.1056\/NEJMoa054209"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nozari Y, Eshraghi A, Talasaz AH, <i>et al<\/i>. Protection from reperfusion injury with intracoronary N-acetylcysteine in patients with STEMI undergoing primary percutaneous coronary intervention in a Cardiac Tertiary Center. Am J Cardiovasc Drugs 2018; 18: 213-21.","DOI":"10.1007\/s40256-017-0258-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Pasupathy S, Tavella R, Grover S, <i>et al<\/i>. Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]). Circulation 2017; 136: 894-903.","DOI":"10.1161\/CIRCULATIONAHA.117.027575"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Talasaz AH, Khalili H, Jenab Y, Salarifar M, Broumand MA, Darabi F. N-Acetylcysteine effects on transforming growth factor-\u03b2 and tumor necrosis factor-\u03b1 serum levels as pro-fibrotic and inflammatory biomarkers in patients following ST-segment elevation myocardial infarction. Version 2. Drugs R D 2013; 13: 199-205.","DOI":"10.1007\/s40268-013-0025-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Talasaz AH, Khalili H, Fahimi F, <i>et al<\/i>. Effects of N-acetylcysteine on the cardiac remodeling biomarkers and major adverse events following acute myocardial infarction: a randomized clinical trial. Am J Cardiovasc Drugs 2014; 14: 51-61.","DOI":"10.1007\/s40256-013-0048-x"},{"key":"14","unstructured":"14. Tanaka A, Suzuki Y, Suzuki N, <i>et al<\/i>. Does N-acetylcysteine reduce the incidence of contrast-induced nephropathy and clinical events in patients undergoing primary angioplasty for acute myocardial infarction? Intern Med 2011; 50: 673-7."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Thayssen P, Lassen JF, Jensen SE, <i>et al<\/i>. Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial. Circ Cardiovasc Interv 2014; 7: 216-24.","DOI":"10.1161\/CIRCINTERVENTIONS.113.000653"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Thiele H, Hildebrand L, Schirdewahn C, <i>et al<\/i>. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial. J Am Coll Cardiol 2010; 55: 2201-9.","DOI":"10.1016\/j.jacc.2009.08.091"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Bhatt DL. Percutaneous coronary intervention in 2018. JAMA 2018; 319: 2127-8.","DOI":"10.1001\/jama.2018.5281"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Giannini F, Candilio L, Mitomo S, <i>et al<\/i>. A practical approach to the management of complications during percutaneous coronary intervention. JACC Cardiovasc Interv 2018; 11: 1797-810.","DOI":"10.1016\/j.jcin.2018.05.052"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007; 357: 1121-35.","DOI":"10.1056\/NEJMra071667"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci U S A 1987; 84: 1404-7.","DOI":"10.1073\/pnas.84.5.1404"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977; 56: 786-94.","DOI":"10.1161\/01.CIR.56.5.786"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Landray MJ, Nuttall SL, Lydakis C, Martin U, Maxwell SR, Lip GY. Oxidative stress after thrombolysis. Lancet 1998; 352: 960.","DOI":"10.1016\/S0140-6736(05)61514-0"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Grech ED, Dodd NJ, Jackson MJ, Morrison WL, Faragher EB, Ramsdale DR. Evidence for free radical generation after primary percutaneous transluminal coronary angioplasty recanalization in acute myocardial infarction. Am J Cardiol 1996; 77: 122-7.","DOI":"10.1016\/S0002-9149(96)90580-9"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Tsujita K, Shimomura H, Kaikita K, <i>et al<\/i>. Long-term efficacy of edaravone in patients with acute myocardial infarction. Circ J 2006; 70: 832-7.","DOI":"10.1253\/circj.70.832"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Brunet J, Boily MJ, Cordeau S, Des Rosiers C. Effects of N-acetylcysteine in the rat heart reperfused after low-flow ischemia: evidence for a direct scavenging of hydroxyl radicals and a nitric oxide-dependent increase in coronary flow. Free Radic Biol Med 1995; 19: 627-38.","DOI":"10.1016\/0891-5849(95)00077-B"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Spies C, Giese C, Meier-Hellmann A, <i>et al<\/i>. The effect of prophylactically administered n-acetylcysteine on clinical indicators for tissue oxygenation during hyperoxic ventilation in cardiac risk patients. Anaesthesist 1996; 45: 343-50 (German).","DOI":"10.1007\/s001010050270"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Anfossi G, Russo I, Massucco P, Mattiello L, Trovati M. Platelet resistance to the antiaggregating effect of N-acetyl-L-cysteine in obese, insulin-resistant subjects. Thromb Res 2003; 110: 39-46.","DOI":"10.1016\/S0049-3848(03)00284-6"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Anfossi G, Russo I, Massucco P, Mattiello L, Cavalot F, Trovati M. N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets. Eur J Clin Invest 2001; 31: 452-61.","DOI":"10.1046\/j.1365-2362.2001.00815.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Gibson KR, Winterburn TJ, Barrett F, Sharma S, MacRury SM, Megson IL. Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes. Cardiovasc Diabetol 2011; 10: 43.","DOI":"10.1186\/1475-2840-10-43"},{"key":"30","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/01.CIR.68.6.1247","volume":"68","year":"1983","unstructured":"30. Horowitz JD, Antman EM, Lorell BH, Barry WH, Smith TW. Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. Circulation 1983; 68: 1247-53.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Packer M, Lee WH, Kessler PD, Gottlieb SS, Medina N, Yushak M. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 1987; 317: 799-804.","DOI":"10.1056\/NEJM198709243171304"},{"key":"32","unstructured":"32. Aihara K, Ikeda Y, Yagi S, Akaike M, Matsumoto T. Transforming Growth Factor-\u03b21 as a Common Target Molecule for Development of Cardiovascular Diseases, Renal Insufficiency and Metabolic Syndrome. Cardiol Res Pract 2010; 2011: 175381."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kelly D, Cockerill G, Ng LL, <i>et al<\/i>. Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study. Eur Heart J 2007; 28: 711-8.","DOI":"10.1093\/eurheartj\/ehm003"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/1\/62_20-519\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T03:56:30Z","timestamp":1611978990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/1\/62_20-519\/_article"}},"subtitle":["A Meta-Analysis and Systematic Review"],"short-title":[],"issued":{"date-parts":[[2021,1,30]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-519","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,30]]}}}